SEOUL PHARMA financial statements, including revenue, expenses, profit, and loss

The total revenue of 018680 for the last quarter is 13.18 B KRW, and it's 3.07% lower compared to the previous quarter. The net income of Q4 23 is 378.00 M KRW.